EpimedX Overview
- Year Founded
-
2011
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
EpimedX General Information
Description
Operator of a research and development company intended to develop gene regulation technology. The company's research and development services include developing gene regulation therapy which helps in treatment for sickle cell disease, beta-thalassemia and malaria, enabling patients to avail a safe, cost-effective and permanent treatment for sickle cell disease, beta-thalassemia, and malaria without dangerous or harmful side effects.
Contact Information
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Delivery
Primary Office
- 755 Research Parkway
- Suite 452
- Oklahoma City, OK 73104
- United States
EpimedX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Out of Business | 01-Oct-2017 | 00.00 | Completed | Out of Business | ||
| 10. Grant | 01-Mar-2017 | 00.00 | Completed | Startup | ||
| 9. Angel (individual) | 06-May-2015 | 00.00 | Completed | Startup | ||
| 8. Grant | 01-Jan-2015 | 00000 | 00.00 | Completed | Startup | |
| 7. Early Stage VC | 03-Sep-2014 | 00000 | 00.00 | Completed | Startup | |
| 6. Angel (individual) | 19-Feb-2014 | 00.00 | Completed | Startup | ||
| 5. Angel (individual) | 16-Oct-2013 | 00.00 | Completed | Startup | ||
| 4. Grant | 01-Feb-2013 | 00000 | 00.00 | Completed | Startup | |
| 3. Grant | $750K | $7.5M | Completed | Startup | ||
| 2. Angel (individual) | 31-Dec-2012 | $7.5M | $7.5M | 00.000 | Completed | Startup |
EpimedX Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Visar Belegu Ph.D | Co-Founder & Board Member |
EpimedX Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Visar Belegu Ph.D | EpimedX | Co-Founder & Board Member | 000 0000 |